The production of immunoreactive-endothelin by bovine 
Introduction
The endothelins are a family of peptides, present as three isoforms (ET-1,2,3) and encoded by three distinct endothelinrelated genes. The active endothelins are 21 amino acid peptides cleaved from a 38-39 amino acid precursor (big ET) by an 'endothelin-converting-enzyme' (Inoue et al., 1989 ).
Endothelin was first described as a vasoconstrictor substance derived from vascular endothelial cells. However, it is now known to be produced in many tissues and different types of cell (Yanagisawa et al, 1988; Kenigsberg et al, 1992) . Further¬ more, within the reproductive system the endometrial stromal and glandular epithelial cells produce endothelin (Ecónomos et al, 1992) . Large amounts of endothelin are also present in human seminal fluid . Endothelin exhibits a potent long-lasting vasoconstrictor/pressor activity and a wide spectrum of actions on a variety of non-vascular tissues including uterine smooth muscle (Kozuka et ah, 1989) . Further¬ more, it possesses mitogenic properties (Komuro et al, 1988) .
Although the presence of endothelin in the reproductive system is well established, its role and regulation within the reproductive system have not been elucidated.
The oviduct provides the optimal environment for the transport of gametes, for the fertilization process, and for the development of early embryos (Sayegh et al, 1991) . Although the oviduct is under endocrine control, locally produced factors play a decisive role in regulation of oviduct function and therefore in the regulation of oviduct wall tone (contractility and relaxation), as well as in the ciliary motion of the oviduct epithelial cells (Yeko and Handler, 1991) .
In and ET-2, and 69% for porcine big ET-1. The crossreactivity observed for ET-3 was < 0.001% (Davenport et al, 1990 (Fig. 2) (Emori et al, 1989 ). This observation is in agreement with a previous report, in which treatment of cultured vascular endothelial cells by A23187 also induced endothelin produc¬ tion (Boulanger and Lüscher, 1990 (Sayegh et al, 1991 (Ecónomos et ., 1992) ; and in the uterus, the contraction in response to endothelin can be reduced by treating the uterine segments with progesterone (McGovern et al., 1992 
